Real-world studies of vaccines aren't directly comparable with clinical trials, but their results are still good news.
Academic rigour, journalistic flair
Articles on COVID-19 vaccine rollout
Displaying all articles
Two experts explain why the UK's vaccine programme has been a success, while abroad China, Russia and India use vaccine supplies to increase their soft power.
Good decisions and investment have built a strong supply chain, while various experts have helped with distribution.
Australia's keenly awaited COVID vaccine rollout begins today. So how will it work, and will the vaccine be the end of all our coronavirus-related problems?
The UK has given around 25% of its population a first dose, but across the world fewer than 3% of people have received a vaccine.
For now, the UK will continue with its age-based prioritisation, but there's a case for key workers and the socially disadvantaged to start feeding into the vaccine queue.
The arrival of COVID-19 vaccines has raised hope for an end to the pandemic. Hopefully that's true, but there are variables. Here are some factors that could affect the success of the vaccine rollout.
Behind Canada’s current COVID-19 vaccine shortage is a decades-long tale of unheeded warnings, missed opportunities and dismantled resources that was never going to end well.
By prioritising vaccination for the elderly, Indonesia may optimally reduce the hospital burden and COVID-19 deaths amid a limited vaccine supply during the first vaccination phase.
The campaign shows promise. But it's not clear if it will preempt and respond to people's concern about vaccine safety.
The COVID-19 vaccine rollout has fallen far short of President Trump's promises. President Biden says he can fix that. Can he?
Two pharmacists involved in COVID-19 vaccine preparation explain the role pharmacists are poised to play in expanding vaccine access.
Massive vaccine distribution efforts take a lot of coordination. The rollout of the Salk polio vaccine in the US in 1955 holds lessons for those delivering COVID-19 shots today.
The shipment of goods to suppliers has become technologically sophisticated. Delays in getting out the COVID-19 vaccine to people show that the breakdowns come down to something more basic.
Australia's expedited plan to start dishing out COVID jabs in mid-late February will call for NASA-like logistical organisation. And ideally, no more clusters of infections to distract frontline workers.
Job Board
-
SCHOLARLY DEVELOPMENT CONSULTANT (RESEARCH)
-
Marketing Officer, Sales and Customer Experience
-
Dean and Pro Vice-Chancellor, Faculty of Health and Environmental Sciences
-
Professional Development Manager - Design and Delivery
-
Molecular Epigenetics Laboratory Head
Top contributors
-
Researcher, Walter and Eliza Hall Institute
-
Professor of Health Economics, UCL
-
Professor of Epidemiology Healthcare Infection and Infectious Diseases Control, UNSW
-
Associate Professor of International Business and Strategy at the D'Amore-McKim School of Business, Northeastern University
-
John F. Smith Memorial Professor of Operations Management, University of Massachusetts Amherst
-
Professor Emeritus of Health Policy and Management, York University, Emergency Physician at University Health Network, Associate Professor of Family and Community Medicine, University of Toronto
-
Director of the Digital Health Enterprise Zone (DHEZ), University of Bradford, Reader in Health Service Operations, University of Bradford
-
Research Fellow, Vaccine Uptake Group, Murdoch Children's Research Institute
-
Director of Skills Education and Clinical Assistant Professor of Pharmacy Practice, Binghamton University, State University of New York
-
NIHR Academic Clinical Fellow in Public Health Medicine, UCL
-
Senior Lecturer in Supply Chain Management, Liverpool John Moores University
-
DPhil Student in Clinical Medicine, Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford
-
PhD student in infectious disease epidemiology, Imperial College London
-
Associate Professor of Viral Immunology, Department of Pathobiology, University of Guelph
-
PhD Student, Centre for Diet and Activity Research (CEDAR) MRC Epidemiology Unit, University of Cambridge
